NEOTROPIX
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers. It develops NTX010, a naturally-occurring virus that attacks and kills neuroendocrine cancers, such as small cell lung cancer, small cell carcinomas originating in other organs, carcinoid, neuroblastoma, and certain other neuroendocrine cancers. The company was founded in 2003 and is headquartered in Malvern, Pennsylvania.
NEOTROPIX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.neotropix.com
Total Employee:
1+
Status:
Active
Contact:
610-296-8660
Email Addresses:
[email protected]
Total Funding:
11.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Sitelinks Search Box Organization Schema IPv6
Current Employees Featured
Founder
Investors List
VIMAC Milestone Medical Fund
VIMAC Milestone Medical Fund investment in Series A - Neotropix
The Aurora Funds
The Aurora Funds investment in Series A - Neotropix
Quaker BioVentures
Quaker BioVentures investment in Series A - Neotropix
Official Site Inspections
http://www.neotropix.com
- Host name: 104.21.2.240
- IP address: 104.21.2.240
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
